VALUATION OF THE PHARMACOKINETIC PROFILE OF 3 HERBAL FORMULATIONS AND PHARMACOKINETIC PROFILE OF SMALL MOLECULES CO-ADMINISTERED WITH HERBAL FORMULATIONS

EVALUATION OF THE PHARMACOKINETIC PROFILE OF 3 HERBAL FORMULATIONS AND PHARMACOKINETIC PROFILE OF SMALL MOLECULES CO-ADMINISTERED WITH HERBAL FORMULATIONS

1.0 TEST SYSTEM DETAILS:

Species : Rattus norvegicus (Rats)

Strain: Sprague Dawley

Age: 6-7 weeks

Sex: Male and Female

No. of animals: Study 1: 8 (4M+4F) animals per group.

: Study 2: 8 (4M+4F)

No. of groups: Study 1: 3 and Study 2: 3

Total animals: Study 1: Twenty-Four animals for 3 compounds – HF1, HF2, HF3

Study 2: Twenty-four animals for pharmacokinetic drug interaction study between HF1 and Amoxicillin

 2.0 TEST ARTICLE DETAILS:

HF1: Curcuma longa-based herbal formulation.
HF2: Withania somnifera-based herbal formulation.
HF3: Tinospora cordifolia and Withania somnifera-based herbal formulation.

3.0 ALLOCATION OF GROUPS:


Study 1, Compounds: HF1, HF2, HF3

Groups	Treatment	Dose; ROA	Dose Volume
G1	Low Dose	10-30 mg/kg, once only, p.o. in 0.5% MC	5 mL/kg
G2	Mid Dose	30-100 mg/kg, once only, p.o. in 0.5% MC
G3	High Dose	100-300 mg/kg, once only, p.o. in 0.5% MC

STUDY 2, Compounds: HF1 + Amoxicillin

Group No.	Group Description	Treatment administered	Dose Volume and Route
G1	HF1 + Amoxicillin Low Dose	HF1: 100-300 mg/kg + Amoxicillin: 50 mg/kg in 0.5% MC	5 ml/kg, p.o.
G2	HF1 + Amoxicillin Mid Dose	HF1: 100-300 mg/kg + Amoxicillin: 100 mg/kg in 0.5% MC
G3	HF1 + Amoxicillin High Dose	HF1: 100-300 mg/kg + Amoxicillin: 200 mg/kg in 0.5% MC

Abbreviations: MC-Methyl Cellulose, p.o.-per os.

1.0 METHOD FOR STUDY 1:

· Animals will be randomized based on their body weights into three groups.

· Rats will be fasted overnight before the conduct of the experiment.

· Before the administration of the test articles blood will be withdrawn from the retro-orbital plexus of the rats (0-hour sample) under transient isoflurane anesthesia.

· Subsequently, animals of groups G1, G2, and G3 will receive HF1 by oral route in a dose range of 10-300 mg/kg.

· Blood (0.2 mL) will again be withdrawn from the retro-orbital plexus of the animals at 10 minutes, 30 minutes, 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, and 24 hours after compound administration.

· Plasma will be separated and submitted for bioanalysis.

· After a 15-day wash-out period, the animals will again be used for the determination of the pharmacokinetic profile of HF2 as mentioned above, and after a further wash-out period of 15 days, the animals will be re-utilized for the evaluation of the pharmacokinetic profile of HF3.


METHOD FOR STUDY 2

· Animals will be randomized based on their body weights into three groups.

· On Day 1, blood will be withdrawn from the animals from the retro-orbital plexus under transient isoflurane anesthesia.

· Subsequently, rats allocated to groups G1-G3 will receive the HF1 formulation orally in the dose range of 100-300 mg/kg and they will concomitantly receive the small molecule in three escalating doses as mentioned in the tables for each study.

· The animals will be administered both test articles for fourteen days.

· On Day 15, from overnight fasted animals, blood will be withdrawn and then they will be orally administered the Ayurvedic formulation along with the small molecule.

· Blood (0.2 mL) will again be withdrawn from the retro-orbital plexus of the animals at 10 minutes, 30 minutes, 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, and 24 hours after compound administration.

· Plasma will be separated and submitted for bioanalysis.

2.0 PARAMETERS TO BE EVALUATED:

· Plasma concentrations of the test articles and derived pharmacokinetic parameters.

3.0 REFERENCE(S):

1. Alnaqeeb, M. et al. Critical pharmacokinetic and pharmacodynamic drug-herb interactions in rats between warfarin and pomegranate peel or guava leaves extracts. BMC Complement. Altern. Med. 19, 1–12 (2019).

2. Li, Y., Liu, C., Zhang, Y., Mi, S. & Wang, N. Pharmacokinetics of ferulic acid and potential interactions with Honghua and clopidogrel in rats. J. Ethnopharmacol. 137, 562–567 (2011).

3. Balap, A., Atre, B., Lohidasan, S., Sinnathambi, A. & Mahadik, K. Pharmacokinetic and pharmacodynamic herb-drug interaction of Andrographis paniculata (Nees) extract and andrographolide with etoricoxib after oral administration in rats. J. Ethnopharmacol. 183, 9–17 (2016).

                                                 END OF THE DOCUMENT  

SHARE

Owner

Hi. I’m Writer of Researchsop.com. ’ ’ Please share these SOPs to all concern pharma people for their development. I like to fullfill the need of curious people. These things inspire me to make things looks better.

• 
• 
• 
• 
•